Se espera que el mercado de la emboloterapia crezca de 3.341,49 millones de dólares en 2021 a 5.758,28 millones de dólares en 2028; Se estima que crecerá a una tasa compuesta anual del 8,1% de 2022 a 2028.
La emboloterapia es una oclusión de las arterias mediante la introducción de globos, coágulos de sangre, espirales o espuma de gel mediante un catéter angiográfico. El catéter ayuda a bloquear un vaso sanguíneo mediante la implantación de un globo o cualquier cuerpo extraño para tratar úlceras sangrantes, cerrar fístulas o malformaciones arteriovenosas, desvascularizar órganos, defectos de los vasos sanguíneos o controlar una hemorragia inoperable. La emboloterapia también se utiliza para detener el flujo sanguíneo hacia y alrededor de un tumor durante la cirugía.
El mercado de la emboloterapia está segmentado por producto, indicación de enfermedad, usuario final del procedimiento y geografía. Por geografía, el mercado está ampliamente segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica. Este informe ofrece información y un análisis en profundidad del mercado con énfasis en parámetros como las tendencias y la dinámica del mercado, y el análisis competitivo de los actores del mercado líderes a nivel mundial.
Información estratégica
< h3>regiones lucrativas para el mercado de emboloterapiaPerspectivas del mercado
La creciente preferencia de los pacientes por procedimientos mínimamente invasivos impulsa el mercado de emboloterapia
El número de Las cirugías mínimamente invasivas están aumentando a medida que los pacientes prefieren cada vez más este tipo de cirugías debido a su menor dolor posoperatorio, complicaciones posoperatorias, estancias hospitalarias más cortas y tiempos de recuperación más rápidos. Se están desarrollando tratamientos no invasivos o mínimamente invasivos como alternativas a la cirugía para pacientes con cáncer de mama en etapa temprana. Por ejemplo, la quimioembolización transarterial, también conocida como TACE, es un procedimiento mínimamente invasivo que normalmente se utiliza para tratar el carcinoma hepatocelular. TACE es para pacientes con cáncer de hígado asintomático e irresecable. TACE se puede utilizar para disminuir el tamaño del tumor y hacer que el paciente sea elegible para un trasplante de hígado. Se considera una evolución de una técnica anteriormente aplicada llamada embolización arterial transcatéter (TAE).
La embolización de la arteria prostática (PAE) también es una terapia mínimamente invasiva implementada como técnica ambulatoria electiva para los síntomas del tracto urinario inferior. (STUI) secundarios a hiperplasia prostática benigna (HPB). El número de pacientes tratados con PAE ha aumentado en los últimos años. Por lo tanto, la creciente preferencia por los procedimientos mínimamente invasivos está impulsando el crecimiento del mercado de la emboloterapia.
Información sobre el producto
Según el producto, el mercado de la emboloterapia se divide en agente embólico y dispositivo de soporte. El agente embólico se subdivide además en microesferas, agentes embólicos líquidos, bobinas embólicas, sistemas de tapón embólico, globos desmontables y otros. El dispositivo de soporte está además subsegmentado en microcatéteres y alambres guía. El segmento de agentes embólicos tiene la mayor participación de mercado en 2021. Además, se prevé que el mismo segmento registre la CAGR más alta durante el período de pronóstico. Los principales factores impulsores del crecimiento del segmento de agentes embólicos son el uso cada vez mayor de agentes embólicos en diversos procedimientos de radiología intervencionista y los avances en agentes embólicos.
Mercado de emboloterapia, por producto: 2022 y 2028
Perspectivas sobre la indicación de enfermedades
Según la indicación de la enfermedad, el mercado de la emboloterapia se segmenta en cáncer, enfermedad vascular periférica, enfermedad neurológica, urológica y nefrológica. trastorno, trastorno gastrointestinal y otros. El cáncer se subsegmenta aún más en cáncer de hígado, cáncer de riñón y otros. Es probable que el segmento del cáncer tenga la mayor participación de mercado en 2021. Además, se espera que el mismo segmento registre la CAGR más rápida de 2022 a 2028. Los principales factores impulsores del crecimiento del segmento del cáncer son la creciente incidencia de cáncer en todo el mundo.
Información sobre la indicación de la enfermedad
Según la indicación de la enfermedad, el mercado de la emboloterapia se segmenta en embolización arterial transcatéter (TAE), radioembolización arterial transcatéter (TARE)/radioterapia interna selectiva (SIRT), y quimioembolización transarterial (TACE). El segmento de embolización arterial transcatéter (TAE) tiene la mayor participación de mercado en 2021. Además, se espera que el mismo segmento registre la CAGR más rápida durante 2022-2028. Los principales factores que impulsan el crecimiento del segmento de embolización arterial transcatéter (TAE) son la creciente preferencia por procedimientos mínimamente invasivos por parte de las personas mayores, la creciente prevalencia de enfermedades crónicas y el rápido crecimiento de la población geriátrica.
Información del usuario final
Según el usuario final, el mercado de la emboloterapia se segmenta en hospitales y hospitales. clínica, centro quirúrgico ambulatorio y otros usuarios finales. En 2021, el hospital & Es probable que el segmento clínico tenga la mayor participación del mercado. Además, se espera que el mismo segmento registre la CAGR más alta de 2022 a 2028. Los principales factores impulsores del crecimiento del sector hospitalario y hospitalario. segmento clínico son la creciente adopción de procedimientos quirúrgicos mínimamente invasivos (incluidos vasculares, urológicos y neurológicos), una mayor afluencia de pacientes en los hospitales para el tratamiento de diversas enfermedades como el cáncer, un número cada vez mayor de procedimientos de embolización realizados en estas instalaciones, una creciente adopción de Dispositivos de emboloterapia avanzados y de última generación para realizar procedimientos complejos con precisión en grandes hospitales, clínicas pequeñas y unidades de cuidados críticos.
Los desarrollos orgánicos, como los lanzamientos y aprobaciones de productos, son estrategias muy adoptadas por las empresas del mercado de la emboloterapia. . A continuación se enumeran algunos de los acontecimientos clave recientes del mercado:
- En abril de 2022, Boston Scientific Corporation recibió 510(k ) autorización de la Administración de Medicamentos y Alimentos de EE. UU. (FDA) para la bobina desmontable de fibra EMBOLD destinada a impedir o reducir el flujo sanguíneo en la vasculatura periférica. La bobina de fibra EMBOLD, la incorporación más reciente a la cartera de oncología intervencionista de Boston Scientific, fue diseñada para su uso en diversos procedimientos de embolización, un tratamiento mínimamente invasivo destinado a bloquear uno o más vasos sanguíneos para obstruir o reducir el flujo sanguíneo.
- En septiembre de 2021, Abbott anunció que adquirió Walk Vascular, LLC, una empresa de dispositivos médicos en etapa comercial con un sistema de trombectomía por aspiración mecánica mínimamente invasivo diseñado para eliminar coágulos de sangre periféricos. Los sistemas de trombectomía periférica de Walk Vascular se incorporarán a la cartera de productos endovasculares existente de Abbott.
Perfiles de la empresa
- Abbott
- Boston Scientific Corporation< /li>
- Cook Medical LLC
- Johnson & Johnson
- Medtronic
- Acandis GmbH
- SSEM Mthembu Medical (Pty) Ltd
- Balt USA LLC
- Stryker
- Guerbet LLC
- Corporación Terumo
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils or gel foam using an angiographic catheter. The catheter aids to block a blood vessel by implanting balloon or any foreign body, in order to treat bleeding ulcer, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defect or for control of inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery.
The factors driving the growth of the embolotherapy market are rising incidence of cancer cases, rising patient preference for minimally invasive procedures, and increasing incidence of hypertension, obesity, smoking, and alcoholism.
The availability of other alternative therapies, and the high cost of embolotherapy are expected to restrict the embolotherapy market growth during the forecast period.
The embolotherapy market majorly consists of the players, such as as Abbott Laboratories, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson Consumer Inc., Medtronic, Acandis GmbH, Terumo Corporation, Balt USA LLC, Stryker Corporation, and Guerbet LLC, among others.
The global embolotherapy market based on product is bifurcated into embolic agents and support devices. The embolic agents is further sub-segmented into microsphere, liquid embolics agents, embolic coils, embolic plug systems, detachable balloons, and others. The support devices is further sub-segmented into microcatheters, and guidewires. The embolic agents segment is likely to hold the largest market share in 2021. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period
The global embolotherapy market based on regions is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In 2021, the North American area held the largest market share. However, the Asia Pacific region is estimated to grow at the fastest CAGR of 8.5% during the forecast period
The List of Companies - Embolotherapy Market
- Abbott Laboratories
- Boston Scientific Corporation
- Cook Medical LLC
- Johnson & Johnson Consumer Inc
- Medtronic
- Acandis GmbH
- Terumo Corporation
- Balt USA LLC
- Stryker Corporation
- Guerbet LLC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Aug 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Aug 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)